CN106062213A - 与自杀风险关联的遗传标志物及其使用方法 - Google Patents

与自杀风险关联的遗传标志物及其使用方法 Download PDF

Info

Publication number
CN106062213A
CN106062213A CN201480076117.6A CN201480076117A CN106062213A CN 106062213 A CN106062213 A CN 106062213A CN 201480076117 A CN201480076117 A CN 201480076117A CN 106062213 A CN106062213 A CN 106062213A
Authority
CN
China
Prior art keywords
seq
suicide
combination
allele
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480076117.6A
Other languages
English (en)
Chinese (zh)
Inventor
C·C·载
J·L·肯尼迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre for Addiction and Mental Health
Original Assignee
Centre for Addiction and Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre for Addiction and Mental Health filed Critical Centre for Addiction and Mental Health
Publication of CN106062213A publication Critical patent/CN106062213A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Data Mining & Analysis (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
CN201480076117.6A 2013-12-23 2014-12-23 与自杀风险关联的遗传标志物及其使用方法 Pending CN106062213A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361920332P 2013-12-23 2013-12-23
US61/920,332 2013-12-23
PCT/CA2014/051257 WO2015095967A1 (en) 2013-12-23 2014-12-23 Genetic markers associated with suicide risk and methods of use thereof

Publications (1)

Publication Number Publication Date
CN106062213A true CN106062213A (zh) 2016-10-26

Family

ID=53477254

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480076117.6A Pending CN106062213A (zh) 2013-12-23 2014-12-23 与自杀风险关联的遗传标志物及其使用方法

Country Status (10)

Country Link
US (1) US10435748B2 (https=)
EP (1) EP3087203B1 (https=)
JP (1) JP6679486B2 (https=)
KR (1) KR20160111925A (https=)
CN (1) CN106062213A (https=)
AU (1) AU2014373588B2 (https=)
CA (1) CA2934815C (https=)
IL (1) IL246417B (https=)
SG (1) SG11201605150YA (https=)
WO (1) WO2015095967A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108148905A (zh) * 2018-02-13 2018-06-12 广州市番禺区中心医院(广州市番禺区人民医院、广州市番禺区心血管疾病研究所) 一段可作为抑郁症标记物的序列

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2891830A1 (en) 2015-05-15 2016-11-15 Centre For Addiction And Mental Health Genetic markers for suicide risk and related methods
JP2019520315A (ja) * 2016-04-29 2019-07-18 スパーナス ファーマシューティカルズ インコーポレイテッド 衝動的攻撃性を監視、診断、及び治療する方法、システム、及びキット
CN108531569B (zh) * 2017-03-03 2021-05-07 上海伯豪医学检验所有限公司 用于强迫症与精神分裂症、抑郁症甄别的基因标志物及其应用
WO2020235721A1 (ko) * 2019-05-23 2020-11-26 울산과학기술원 다중 오믹스 분석을 이용한 우울증 또는 자살 위험 예측용 마커 발굴 방법, 우울증 또는 자살 위험 예측용 마커, 및 다중 오믹스 분석을 이용한 우울증 또는 자살 위험 예측 방법
WO2024215722A1 (en) * 2023-04-10 2024-10-17 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing and treating depression and suicide risk

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050228172A9 (en) * 2000-10-24 2005-10-13 Wang David G Identification and mapping of single nucleotide polymorphisms in the human genome
US20060024715A1 (en) * 2004-07-02 2006-02-02 Affymetrix, Inc. Methods for genotyping polymorphisms in humans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120094855A1 (en) * 2008-09-18 2012-04-19 Max Planck Society Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi)
EP2166112B1 (en) 2008-09-18 2013-06-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Means and methods for diagnosing predisposition for treatment emergent suicidal ideation
KR101249635B1 (ko) * 2010-10-13 2013-04-01 서울대학교산학협력단 양극성 장애 진단용 ｅｇｒ2 유전자 ｓｎｐ, 그를 포함하는 마이크로어레이 및 키트

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050228172A9 (en) * 2000-10-24 2005-10-13 Wang David G Identification and mapping of single nucleotide polymorphisms in the human genome
US20060024715A1 (en) * 2004-07-02 2006-02-02 Affymetrix, Inc. Methods for genotyping polymorphisms in humans

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SCOTT LJ ET AL: "A genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry", 《PNAS》 *
WILLOUR VL ET AL: "A genome-wide association study of attempted suicide", 《MOL PSYCHIATRY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108148905A (zh) * 2018-02-13 2018-06-12 广州市番禺区中心医院(广州市番禺区人民医院、广州市番禺区心血管疾病研究所) 一段可作为抑郁症标记物的序列

Also Published As

Publication number Publication date
EP3087203A1 (en) 2016-11-02
US20170002412A1 (en) 2017-01-05
CA2934815A1 (en) 2015-07-02
EP3087203A4 (en) 2017-09-20
WO2015095967A1 (en) 2015-07-02
SG11201605150YA (en) 2016-07-28
CA2934815C (en) 2022-01-04
AU2014373588B2 (en) 2021-04-01
KR20160111925A (ko) 2016-09-27
AU2014373588A1 (en) 2016-07-21
JP2017503493A (ja) 2017-02-02
US10435748B2 (en) 2019-10-08
IL246417B (en) 2020-08-31
IL246417A0 (en) 2016-08-31
EP3087203B1 (en) 2019-09-11
JP6679486B2 (ja) 2020-04-15

Similar Documents

Publication Publication Date Title
Smith et al. Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex
Volpi et al. Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia
Zimmerman et al. A novel custom resequencing array for dilated cardiomyopathy
JP6679486B2 (ja) 自殺リスクに関連する遺伝子マーカーおよびその使用の方法
JP2004525650A (ja) 筋緊張性ジストロフィー２型に関連するイントロン、および使用方法
Tomar et al. Mutational spectrum of dystrophinopathies in Singapore: Insights for genetic diagnosis and precision therapy
Gallitano et al. Family-based association study of early growth response gene 3 with child bipolar I disorder
JP2020089370A (ja) 抗精神病薬に基づく処置により誘導される錐体外路症状（ｅｐｓ）の発症を予測する方法
WO2012082912A2 (en) Markers related to age-related macular degeneration and uses therefor
Enomoto et al. Divergent variant patterns among 19 patients with Rubinstein‐Taybi syndrome uncovered by comprehensive genetic analysis including whole genome sequencing
Xu et al. Decoding complexity: The role of long-read sequencing in unraveling genetic disease etiologies
Srivastava et al. Spinal muscular atrophy–a revisit of the diagnosis and treatment modalities
JP5721150B2 (ja) 加齢黄斑変性症の発症リスクの予測方法
Cossée et al. Exonic microdeletions in the X-linked PQBP1 gene in mentally retarded patients: a pathogenic mutation and in-frame deletions of uncertain effect
JP6524073B2 (ja) 抗精神病薬誘導体重増加に関連する遺伝子マーカーおよびその使用のための方法
US20120208718A1 (en) Schizophrenia treatment response biomarkers
US20230220472A1 (en) Deterimining risk of spontaneous coronary artery dissection and myocardial infarction and sysems and methods of use thereof
KR20230005816A (ko) 신경전달물질 수송체 억제제의 효능을 평가하기 위한 조성물 및 방법
JP6788879B2 (ja) 末梢動脈疾患検査方法及び検査用試薬
CN103266181B (zh) 一种用于检测ttr基因突变g307c的试剂盒
US20100129805A1 (en) Slc1a1 antipsychotic drug response markers
JP5644009B2 (ja) 一塩基多型を用いた炎症性疾患の判定方法
Huang et al. Evaluation of relationship between KEAP1 gene and genetic susceptibility of deep vein thrombosis after orthopedic surgery in Han Chinese population
Bergen et al. Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3–7 October 2010
KR20250053768A (ko) 회전근개 파열 예측 또는 진단용 조성물, 키트 및 이를 이용한 진단 방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161026